Form 4: Krystal Biotech Director Sells Shares
Insider Transaction (Form 4)
Dino A Rossi, a Director of Krystal Biotech, Inc., sold 25,000 shares of common stock on August 14, 2026.
Summary
- Bona fide gift: disposed of 3,691 Common Stock on August 14, 2026; holds 75,000 after (Direct).
- Open-market sale: disposed of 341 Common Stock at $325.60 ($111,029) on August 14, 2026; holds 74,659 after (Direct).
- Open-market sale: disposed of 2,287 Common Stock at $326.60 ($746,941) on August 14, 2026; holds 72,372 after (Direct).
- Open-market sale: disposed of 5,226 Common Stock at $327.39 ($1,710,961) on August 14, 2026; holds 67,146 after (Direct).
- Open-market sale: disposed of 1,687 Common Stock at $328.52 ($554,205) on August 14, 2026; holds 65,459 after (Direct).
- Open-market sale: disposed of 7,428 Common Stock at $329.60 ($2,448,280) on August 14, 2026; holds 58,031 after (Direct).
- Open-market sale: disposed of 4,896 Common Stock at $330.36 ($1,617,422) on August 14, 2026; holds 53,135 after (Direct).
- Open-market sale: disposed of 3,095 Common Stock at $331.43 ($1,025,786) on August 14, 2026; holds 50,040 after (Direct).
- Open-market sale: disposed of 40 Common Stock at $333.23 ($13,329) on August 14, 2026; holds 50,000 after (Direct).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $8,227,953 of stock on the open market.
Insider Transactions
Dino A Rossi — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Bona fide gift | Common Stock | 3,691 | — | — | 75,000 |
| 2026-08-14 | Open-market sale | Common Stock | 341 | $326 | $111.0K | 74,659 |
| 2026-08-14 | Open-market sale | Common Stock | 2,287 | $327 | $746.9K | 72,372 |
| 2026-08-14 | Open-market sale | Common Stock | 5,226 | $327 | $1.7M | 67,146 |
| 2026-08-14 | Open-market sale | Common Stock | 1,687 | $329 | $554.2K | 65,459 |
| 2026-08-14 | Open-market sale | Common Stock | 7,428 | $330 | $2.4M | 58,031 |
| 2026-08-14 | Open-market sale | Common Stock | 4,896 | $330 | $1.6M | 53,135 |
| 2026-08-14 | Open-market sale | Common Stock | 3,095 | $331 | $1.0M | 50,040 |
| 2026-08-14 | Open-market sale | Common Stock | 40 | $333 | $13.3K | 50,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Bona fide gift (3,691 shares) |
| 2026-08-14 | Open-market sale (341 shares) |
| 2026-08-14 | Open-market sale (2,287 shares) |
| 2026-08-14 | Open-market sale (5,226 shares) |
| 2026-08-14 | Open-market sale (1,687 shares) |
| 2026-08-14 | Open-market sale (7,428 shares) |
| 2026-08-14 | Open-market sale (4,896 shares) |
| 2026-08-14 | Open-market sale (3,095 shares) |
| 2026-08-14 | Open-market sale (40 shares) |
Keywords
insider transaction, Form 4, KRYS, Krystal Biotech, Inc., bearish, Dino A Rossi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.